Inhibition of skeletal muscle differentiation by calciprotein particles in human primary myoblasts-Reference-Cited by-同舟云学术

Inhibition of skeletal muscle differentiation by calciprotein particles in human primary myoblasts

Published:2024-07-13 Issue:4 Volume:45 Page:173-177
ISSN:0388-6107
Container-title:Biomedical Research
language:en
Short-container-title:Biomed. Res.

Author:

KOHNO Shohei¹,UNO Eisuke²,GOISHI Kazuto²,KHARAGHANI Davood³,UCHIBE Kenta¹,TERAYAMA Ryuji¹

Affiliation:

1. Department of Maxillofacial Anatomy and Neuroscience, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima 734-8553, Japan

2. Faculty of Dentistry, Hiroshima University, Hiroshima 734-8553, Japan

3. Department of Medicine, Clinical Academic Building, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey 08854, USA

Publisher

Biomedical Research Press

Link

https://www.jstage.jst.go.jp/article/biomedres/45/4/45_173/_pdf

Reference21 articles.

1. Aghagolzadeh P, Bachtler M, Bijarnia R, Jackson C, Smith ER, et al. (2016) Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α. Atherosclerosis 251, 404–414.

2. Alcalde-Estévez E, Sosa P, Asenjo-Bueno A, Plaza P, Olmos G, et al. (2021) Uraemic toxins impair skeletal muscle regeneration by inhibiting myoblast proliferation, reducing myogenic differentiation, and promoting muscular fibrosis. Sci Rep 11, 1–17.

3. Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, et al. (2020) Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 395, 709–733.

4. Brightwell CR, Kulkarni AS, Paredes W, Zhang K, Perkins JB, et al. (2021) Muscle fibrosis and maladaptation occur progressively in CKD and are rescued by dialysis. JCI Insight 6, e150112.

5. Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, et al. (2018) Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet 392, 2052–2090.